Unitaid UN

=<div><div>PLANDEMIC</div><div>
</div><div><a href="https://docs.google.com/document/d/1uLTK6L1f8v8BjtPBvuAwn1nTAewm6tFbwMb1Z-va_ZQ/edit?usp=sharing">https://docs.google.com/document/d/1uLTK6L1f8v8BjtPBvuAwn1nTAewm6tFbwMb1Z-va_ZQ/edit?usp=sharing</a></div><div>
</div><div>OANN</div><div>
</div><div>=</div><div><div>=</div><div><a href="https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/">https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/</a></div><div>
</div><div>the claim: China owns the patent for the drug remdesivir</div>The origins, utility and ownership of potential coronavirus treatments are an increasingly discussed subject online, making the topic a ripe target for conspiracy theories.The drug remdesivir has emerged as a centerpiece of many theories claiming that various groups and individuals stand to benefit from the drug's use as a treatment for COVID-19.“Isn’t it just an interesting coincidence that Remdesivir is made by Gilead and is the 'CURE' for COVID-19 … . And here’s where it gets interesting China holds the patent on the drug through an agreement with Gilead’s drug patent sharing subsidy branch called UNITAID who has an office near Wuhan,” <a href="https://www.facebook.com/photo.php?fbid=10212873886320710&set=a.1267424704496&type=3&theater" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">a graphic on Facebook shared more than 300 times reads</a>.And you’ll never guess who are the main financial investors in UNITAID…none other than George Soros, Bill & Melinda Gates, and WHO,” the post continues.Remdesivir is an antiviral drug developed by the firm Gilead Sciences, which maintains the U.S. patent on the drug as a coronavirus treatment. No Chinese institution has a recognized patent for the drug.Fact check: <a href="https://www.usatoday.com/story/news/factcheck/2020/03/23/coronavirus-fact-check-whats-true-and-whats-false-covid-19/2898043001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">What's true and what's false about coronavirus?</a><h2 class="gnt_ar_b_h2" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: 26px; margin: 28px 0px 18px; background-color: rgb(255, 255, 255);">Remdesivir’s patents</h2><a href="https://www.gilead.com/purpose/advancing-global-health/covid-19/about-remdesivir" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Remdesivir </a>has been <a href="https://www.gilead.com/-/media/gilead-corporate/files/pdfs/covid-19/gilead_rdv-development-fact-sheet-2020.pdf" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">researched by Gilead as far back as 2009</a> as a treatment for viruses ranging from hepatitis C and respiratory syncytial virus to Ebola and now COVID-19.Gilead first <a href="https://patents.google.com/patent/US9724360B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">received a patent for the drug</a> as a treatment for Ebola in 2017. In fall 2015, Gilead applied for two patents for remdesivir, one for <a href="https://patents.google.com/patent/US10251904B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">combating coronaviruses</a> and <a href="https://patents.google.com/patent/US9724360B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">another for filoviruses</a>, the family of pathogens that includes Ebola. Both were approved in spring 2019. <h2 class="gnt_ar_b_h2" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: 26px; margin: 28px 0px 18px; background-color: rgb(255, 255, 255);">Use treating COVID-19</h2><a href="https://www.nih.gov/news-events/news-releases/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">In April, a National Institutes of Health study</a> found the drug to speed the recovery time of critically ill COVID-19 patients by 31%. Gilead has since said that, with federal assistance, it will begin <a href="https://www.usatoday.com/story/money/business/2020/05/03/coronavirus-treatment-drug-remdesivir-coming-hospitals-week/3074612001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">deploying remdesivir to hospitals around the country</a>.Gilead Sciences remains the only organization in the world entitled to intellectual property rights over remdesivir as a treatment for COVID-19.In January, Chinese researchers at the Wuhan Institute of Virology <a href="https://www.bloomberg.com/news/articles/2020-02-05/china-is-trying-to-patent-gilead-s-experimental-coronavirus-drug" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">filed for a patent to use remdesivir</a> as a treatment against COVID-19. At the time, no research had been published showing that remdesivir was effective. Even so, the drug was already <a href="http://www.xinhuanet.com/english/2020-02/11/c_138771962.htm" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">being deployed for clinical trials in Wuhan</a> and elsewhere.In early February, the Chinese company BrightGene Bio-Medical Technology also said that it had been <a href="https://www.thepharmaletter.com/in-brief/brief-china-s-brightgene-latest-to-copy-remdesivir-antiviral" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">approved to produce remdesivir</a> by the Chinese government, though <a href="https://time.com/5793357/china-company-censured-coronavirus/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">regulators eventually said the company had not received approval </a>from the government nor Gilead Sciences.The Chinese government has not approved a patent for the drug, a move that would likely <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">draw further criticism from the United States</a> and others concerned about Chinese violations of international norms regarding intellectual property.Given the severity of the pandemic globally, however, several international groups have made repeated calls for the sharing of intellectual property rights relating to medicines and vaccines that can combat the new coronavirus.Video:<a href="https://www.usatoday.com/videos/news/health/2020/04/30/remdesivir-antiviral-drug-tested-against-covid-19/3061178001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">What to know about antiviral drug remdesivir and COVID-19</a><h2 class="gnt_ar_b_h2" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: 26px; margin: 28px 0px 18px; background-color: rgb(255, 255, 255);">Unitaid, Gates Foundation, WHO and potential international cooperation on treatments</h2><a href="https://unitaid.org/about-us/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Unitaid </a>is not a subsidiary of Gilead Sciences but rather a global health research initiative backed by the <a href="https://www.un.org/en/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">United Nations</a> and <a href="https://www.who.int/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">World Health Organization</a> to fund research projects combating a range of viruses.Founded by the French government in 2006, the group is headquartered in Geneva and <a href="https://unitaid.org/how-we-work/donors/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">funded by the governments</a> of Brazil, Chile, France, Norway, South Korea, Spain and the United Kingdom, as well as the <a href="https://unitaid.org/news-blog/unitaid-hails-new-us-50-million-contribution-bill-melinda-gates-foundation/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Bill & Melinda Gates Foundation</a>.Unitaid has no financial ties to George Soros or the Open Society Foundations, which Soros founded and manages.The Bill & Melinda Gates Foundation <a href="https://www.usatoday.com/story/news/factcheck/2020/05/14/fact-check-anthony-fauci-bill-gates-wont-profit-remdesivir/3120063001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">also does not have a patent</a> for the remdesivir and doesn't stand to profit from its use.Fact check:<a href="https://www.usatoday.com/story/news/factcheck/2020/05/14/fact-check-anthony-fauci-bill-gates-wont-profit-remdesivir/3120063001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Dr. Anthony Fauci, Bill Gates won't profit from drug remdesivir</a>In late March, Unitaid’s chair <a href="https://www.ft.com/content/b69afd98-a8af-40d9-b520-4231d9cac68f" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Marisol Touraine told the Financial Times</a> that “extraordinary circumstances” warranted “extraordinary solutions,” while endorsing a <a href="https://healthpolicy-watch.org/costa-rica-urges-who-to-lead-global-initiative-for-pooled-rights-to-covid-19-diagnostics-drugs-vaccines/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">WHO-backed plan for companies to voluntarily pool intellectual property</a> governing any treatments or research that can be used in the fight against COVID-19.“I welcome his initiative & call for pooled rights to #COVID19 diagnostics, drugs & vaccines,” Tedros Adhanom, director-general of the World Health Organization, <a href="https://twitter.com/DrTedros/status/1243090557804691468" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">said of the proposal</a>, which would allow companies around the world to share intellectual property rights and produce patented goods with the consent of other members in any such initiative.the strategy is an attempt to temper competition between firms and countries as the <a href="https://www.usatoday.com/story/news/health/2020/05/09/coronavirus-vaccine-race-us-testing/5179665002/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">race to find treatments and a potential vaccine for the new coronavirus intensifies</a>.On April 24, the WHO <a href="https://www.who.int/who-documents-detail/access-to-covid-19-tools-(act)-accelerator" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">launched a cooperative initiative</a> called “Access to COVID-19 Tools Accelerator,” which would coordinate and fund support for coronavirus research by member states and institutions. Unitaid and the Bill & Melinda Gates Foundation are listed as cosignatories.The United States and China are not members of the coalition, <a href="https://www.statnews.com/pharmalot/2020/04/24/covid19-coronavirus-who-vaccines-medicines-access/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">which may ultimately include a patent pooling resolution</a>. Gilead Sciences has not licensed the production of remdesivir to any other firm as it continues to ramp up production of the drug.Fact check: <a href="https://www.usatoday.com/story/news/factcheck/2020/05/09/fact-check-price-didnt-push-remdesivir-over-hydroxychloroquine/3094440001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Price didn't drive promotion of remdesivir over hydroxychloroquine</a><h2 class="gnt_ar_b_h2" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: 26px; margin: 28px 0px 18px; background-color: rgb(255, 255, 255);">Our ruling: False</h2>No Chinese firm has an approved claim to a patent for remdesivir. No international organizations – including the Gates Foundations, Unitaid, the Open Societies Foundation, or the WHO – hold patents for the antiviral drug either. While there are efforts to pool patents for potential treatments, and thus alter the financial incentives of the parties to such pooling arrangements, the United States and China are not obligating their domestic firms to join these movements. Gilead Sciences, which owns the U.S. patent for promising COVID-19 treatment remdesivir, solely maintains the intellectual property rights to the drug. We rate this claim FALSE because it is not supported by our research. <h2 class="gnt_ar_b_h2" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: 26px; margin: 28px 0px 18px; background-color: rgb(255, 255, 255);">Our fact-check sources:</h2><ul class="gnt_ar_b_ul" style="list-style: none; padding: 0px 0px 0px 30px; background-color: rgb(255, 255, 255);"><li class="gnt_ar_b_ul_li"><a href="https://www.gilead.com/purpose/advancing-global-health/covid-19/about-remdesivir" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Gilead Sciences, About Remdesivir</a></li><li class="gnt_ar_b_ul_li"><a href="https://www.gilead.com/-/media/gilead-corporate/files/pdfs/covid-19/gilead_rdv-development-fact-sheet-2020.pdf" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Gilead Sciences, Early Development of Remdesivir</a></li><li class="gnt_ar_b_ul_li"><a href="https://patents.google.com/patent/US9724360B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Gilead Sciences 2017 Patent for Remdesivir</a></li><li class="gnt_ar_b_ul_li"><a href="https://patents.google.com/patent/US10251904B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Gilead Sciences 2019 Patent for Remdesivir Usage Against Coronaviruses</a></li><li class="gnt_ar_b_ul_li"><a href="https://patents.google.com/patent/US9724360B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Gilead Sciences 2019 Patent for Remdesivir Usage Against Filoviruses</a></li><li class="gnt_ar_b_ul_li"><a href="https://www.nih.gov/news-events/news-releases/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">National Institutes of Health, NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19</a></li><li class="gnt_ar_b_ul_li"><a href="https://www.usatoday.com/story/money/business/2020/05/03/coronavirus-treatment-drug-remdesivir-coming-hospitals-week/3074612001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">USA TODAY, Coronavirus treatment drug remdesivir to arrive in hospitals this week, Gilead CEO says</a></li><li class="gnt_ar_b_ul_li"><a href="https://www.bloomberg.com/news/articles/2020-02-05/china-is-trying-to-patent-gilead-s-experimental-coronavirus-drug" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Bloomberg News, China Wants to Patent Gilead’s Experimental Coronavirus Drug</a></li><li class="gnt_ar_b_ul_li"><a href="http://www.xinhuanet.com/english/2020-02/11/c_138771962.htm" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">XinhuaNet, Over 60 percent of patients in clinical trial may try Remdesivir: expert</a></li><li class="gnt_ar_b_ul_li"><a href="https://www.thepharmaletter.com/in-brief/brief-china-s-brightgene-latest-to-copy-remdesivir-antiviral" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">ThePharmaLetter, China's BrightGene latest to copy remdesivir antiviral</a></li><li class="gnt_ar_b_ul_li"><a href="https://time.com/5793357/china-company-censured-coronavirus/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Bloomberg, Chinese Biotech Company Censured for Claiming It Could Make Experimental Coronavirus Drug</a></li><li class="gnt_ar_b_ul_li"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">European Journal of Risk Regulation, COVID-19, Patents and the Never-Ending Tension between Proprietary Rights and the Protection of Public Health</a></li><li class="gnt_ar_b_ul_li"><a href="https://unitaid.org/about-us/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Unitaid, About Us</a></li><li class="gnt_ar_b_ul_li"><a href="https://unitaid.org/how-we-work/donors/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Unitaid, Donors</a></li><li class="gnt_ar_b_ul_li"><a href="https://unitaid.org/news-blog/unitaid-hails-new-us-50-million-contribution-bill-melinda-gates-foundation/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Gates Foundation, Press release about donation to Unitaid</a></li><li class="gnt_ar_b_ul_li"><a href="https://www.usatoday.com/story/news/factcheck/2020/05/14/fact-check-anthony-fauci-bill-gates-wont-profit-remdesivir/3120063001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">USA TODAY, Fact check: Dr. Anthony Fauci, Bill Gates won't profit from drug remdesivir</a></li><li class="gnt_ar_b_ul_li"><a href="https://www.ft.com/content/b69afd98-a8af-40d9-b520-4231d9cac68f" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Financial Times, Big drugmakers under pressure to share patents against coronavirus</a></li><li class="gnt_ar_b_ul_li"><a href="https://twitter.com/DrTedros/status/1243090557804691468" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Tedros Adhanom Ghebreyesus March 26 Tweet</a></li><li class="gnt_ar_b_ul_li"><a href="https://www.usatoday.com/story/news/health/2020/05/09/coronavirus-vaccine-race-us-testing/5179665002/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">USA TODAY, Latest on global search for coronavirus vaccine: 1st US candidate set for Phase 2; WHO tracks 8 efforts; Pfizer tests in humans</a></li><li class="gnt_ar_b_ul_li"><a href="https://www.who.int/who-documents-detail/access-to-covid-19-tools-(act)-accelerator" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">World Health Organization, Access to COVID-19 Tools Accelerator</a></li><li class="gnt_ar_b_ul_li"><a href="https://www.statnews.com/pharmalot/2020/04/24/covid19-coronavirus-who-vaccines-medicines-access/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">STAT News, WHO launches ambitious global project to develop Covid-19 medical products</a></li></ul><div>=</div></div><div>=</div><div><a href="https://en.wikipedia.org/wiki/Unitaid">https://en.wikipedia.org/wiki/Unitaid</a></div><div>
</div><div>Unitaid is a global health initiative that works with partners to bring about innovations to prevent, diagnose and treat major diseases in low- and middle-income countries, with an emphasis on tuberculosis, malaria, and HIV/AIDS and its deadly co-infections. Founded in 2006, the organization funds the final stages of research and development of new drugs, diagnostics and disease-prevention tools, helps produce data supporting guidelines for their use, and works to allow more affordable generic medicines to enter the marketplace in low- and middle-income countries. Hosted by the World Health Organization (WHO) in Geneva, Unitaid was established by the governments of Brazil, Chile, France, Norway and the United Kingdom.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-4" style="text-decoration-line: none; background: none;">[4]</a>As of 2019, Unitaid manages a portfolio of 48 grants worth around US$1.3 billion. More than half of Unitaid's projects contribute to the global fight against antimicrobial resistance.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-2EE95-5" style="text-decoration-line: none; background: none;">[5]</a>Unitaid supports programs that are implemented by organizations such as Coalition Plus, the <a href="https://en.wikipedia.org/wiki/Clinton_Foundation#Clinton_Health_Access_Initiative.28CHAI.29" title="Clinton Foundation" style="background: none; text-decoration-line: none;">Clinton Health Access Initiative</a>, Elizabeth Glaser Pediatric AIDS Foundation, Expertise France, <a href="https://en.wikipedia.org/wiki/The_Global_Fund" class="mw-redirect" title="The Global Fund" style="background: none; text-decoration-line: none;">The Global Fund</a>, <a href="https://en.wikipedia.org/wiki/Foundation_for_Innovative_New_Diagnostics" title="Foundation for Innovative New Diagnostics" style="background: none; text-decoration-line: none;">Foundation for Innovative New Diagnostics</a>, <a href="https://en.wikipedia.org/wiki/M%C3%A9decins_Sans_Fronti%C3%A8res" title="Médecins Sans Frontières" style="background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Médecins Sans Frontières</a>,<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-MSF_10May2012-6" style="text-decoration-line: none; background: none;">[6]</a> Medicines for Malaria Venture,<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-MMV_11Dec2012-7" style="text-decoration-line: none; background: none;">[7]</a> <a href="https://en.wikipedia.org/wiki/Stop_TB_Partnership" title="Stop TB Partnership" style="background: none; text-decoration-line: none;">Stop TB Partnership</a>,<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-StopTBPartnership_14Jun2012-8" style="text-decoration-line: none; background: none;">[8]</a> <a href="https://en.wikipedia.org/wiki/TB_Alliance" title="TB Alliance" style="background: none; text-decoration-line: none;">TB Alliance</a>,<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-TBAlliance_19Dec2012-9" style="text-decoration-line: none; background: none;">[9]</a> UNICEF and others.<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading" style="border: 1px solid rgb(162, 169, 177); background-color: rgb(248, 249, 250); padding: 7px; display: table;"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="direction: ltr; position: absolute; opacity: 0; z-index: -1; display: none;" /><div class="toctitle" lang="en" dir="ltr" style="text-align: center; direction: ltr;">
</div><ul style="list-style-image: none; margin: 0.3em 0px; padding: 0px; list-style-type: none;"><li class="toclevel-1 tocsection-1" style="margin-bottom: 0.1em;"><a href="https://en.wikipedia.org/wiki/Unitaid#Areas_of_work" style="text-decoration-line: none; background: none;">1Areas of work</a></li><li class="toclevel-1 tocsection-2" style="margin-bottom: 0.1em;"><a href="https://en.wikipedia.org/wiki/Unitaid#Financing" style="text-decoration-line: none; background: none;">2Financing</a></li><li class="toclevel-1 tocsection-3" style="margin-bottom: 0.1em;"><a href="https://en.wikipedia.org/wiki/Unitaid#History" style="text-decoration-line: none; background: none;">3History</a></li><li class="toclevel-1 tocsection-4" style="margin-bottom: 0.1em;"><a href="https://en.wikipedia.org/wiki/Unitaid#Structure" style="text-decoration-line: none; background: none;">4Structure</a></li><li class="toclevel-1 tocsection-5" style="margin-bottom: 0.1em;"><a href="https://en.wikipedia.org/wiki/Unitaid#See_also" style="text-decoration-line: none; background: none;">5See also</a></li><li class="toclevel-1 tocsection-6" style="margin-bottom: 0.1em;"><a href="https://en.wikipedia.org/wiki/Unitaid#References" style="text-decoration-line: none; background: none;">6References</a></li><li class="toclevel-1 tocsection-7" style="margin-bottom: 0.1em;"><a href="https://en.wikipedia.org/wiki/Unitaid#External_links" style="text-decoration-line: none; background: none;">7External links</a></li></ul></div><h2 style="background: none rgb(255, 255, 255); font-weight: normal; margin: 1em 0px 0.25em; overflow: hidden; padding: 0px; border-bottom: 1px solid rgb(162, 169, 177); line-height: 1.3;">Areas of work[<a href="https://en.wikipedia.org/w/index.php?title=Unitaid&action=edit&section=1" title="Edit section: Areas of work" style="text-decoration-line: none; background: none;">edit</a>]</h2><ul style="list-style-image: url(" w="w" skins="skins" vector="Vector" resources="resources" skins.vector.styles="skins.vector.styles" images="images" bullet-icon.svg="bullet-icon.svg" d4515="d4515" margin="margin" em="em" px="px" padding="padding" background-color="background-color" rgb="rgb"><li style="margin-bottom: 0.1em;">Unitaid and partners have brought new, affordable HIV medicines to people in Africa in three years, three times faster than for previous generations of antiretrovirals. Further reductions in prices are expected to save the global health response US$300 million each year.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-2EE95-5" style="text-decoration-line: none; background: none;">[5]</a></li><li style="margin-bottom: 0.1em;">Unitaid and partners have revolutionized childhood TB treatment with quality paediatric medicines that are affordable and taste good. Unitaid is also investing in better approaches to help find the one million children affected by TB each year, and to identify drug-resistant strains of TB in patients with genome-based diagnostic technologies.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-2EE95-5" style="text-decoration-line: none; background: none;">[5]</a></li><li style="margin-bottom: 0.1em;">The Unitaid-supported ACCESS-SMC pilot project (2014-2018) demonstrated that providing small children with oral medication during the rainy season in Africa's Sahel region protects against malaria, and that the strategy is feasible and cost effective. As the result of the project, 12 countries were delivering seasonal malaria chemoprevention as of mid-2019.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-2EE95-5" style="text-decoration-line: none; background: none;">[5]</a></li><li style="margin-bottom: 0.1em;">Unitaid and its partners are finding new ways to manage and mitigate mosquitoes' resistance to insecticide with the first long-lasting insecticides recommended by WHO in 40 years, new bed nets, anti-parasitic drugs, and treated plastic sheets that drive mosquitoes away from where people live.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-2EE95-5" style="text-decoration-line: none; background: none;">[5]</a></li><li style="margin-bottom: 0.1em;">Unitaid and partners have succeeded in introducing quality-assured, affordable self-testing kits across Africa in the space of three years. Fifty-nine countries now have policies on HIV self-testing.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-2EE95-5" style="text-decoration-line: none; background: none;">[5]</a></li><li style="margin-bottom: 0.1em;">In 2010, Unitaid <a rel="nofollow" class="external text" href="https://unitaid.eu/project/medicines-patent-pool/#en" style="text-decoration-line: none; background: linear-gradient(transparent, transparent) right center no-repeat, url(" w="w" skins="skins" vector="Vector" resources="resources" skins.vector.styles="skins.vector.styles" images="images" external-link-ltr-icon.svg="external-link-ltr-icon.svg" b4b84="b4b84" padding-right="padding-right" px="px">created</a> and invested in the <a href="https://en.wikipedia.org/wiki/Medicines_Patent_Pool" title="Medicines Patent Pool" style="text-decoration-line: none; background: none;">Medicines Patent Pool (MPP)</a> to negotiate voluntary licenses for HIV medicines. MPP's work helped bring about the widespread use of tenofovir for HIV treatment, which resulted in a savings of $195 million in drug costs between 2012 and 2015.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-10" style="text-decoration-line: none; background: none;">[10]</a></li></ul><h2 style="background: none rgb(255, 255, 255); font-weight: normal; margin: 1em 0px 0.25em; overflow: hidden; padding: 0px; border-bottom: 1px solid rgb(162, 169, 177); line-height: 1.3;">Financing[<a href="https://en.wikipedia.org/w/index.php?title=Unitaid&action=edit&section=2" title="Edit section: Financing" style="text-decoration-line: none; background: none;">edit</a>]</h2><ul style="list-style-image: url(" w="w" skins="skins" vector="Vector" resources="resources" skins.vector.styles="skins.vector.styles" images="images" bullet-icon.svg="bullet-icon.svg" d4515="d4515" margin="margin" em="em" px="px" padding="padding" background-color="background-color" rgb="rgb"><li style="margin-bottom: 0.1em;">Unitaid’s main donors are France, the United Kingdom, Norway, the Bill & Melinda Gates Foundation, Brazil, Spain, the Republic of Korea, and Chile.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-11" style="text-decoration-line: none; background: none;">[11]</a></li></ul>The single main source of income is an airline ticket tax currently in effect in ten countries: Cameroon, Chile, Congo, France, Guinea, Madagascar, Mali, Mauritius, Niger and the Republic of Korea. In France, a tax of €2.63 to €63.07 (2020) is added to the price of each airline ticket. The higher fees are for first- or business-class passengers traveling to destinations outside Europe.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-12" style="text-decoration-line: none; background: none;">[12]</a> In January 2013, France’s Directorate General for Civil Aviation announced that the French air ticket tax had collected 1 billion euros since its inception.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-13" style="text-decoration-line: none; background: none;">[13]</a>Norway allocates part of its tax on carbon dioxide emissions from aviation to Unitaid, and the United Kingdom contributes through multi-year commitments.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-14" style="text-decoration-line: none; background: none;">[14]</a><h2 style="background: none rgb(255, 255, 255); font-weight: normal; margin: 1em 0px 0.25em; overflow: hidden; padding: 0px; border-bottom: 1px solid rgb(162, 169, 177); line-height: 1.3;">History[<a href="https://en.wikipedia.org/w/index.php?title=Unitaid&action=edit&section=3" title="Edit section: History" style="text-decoration-line: none; background: none;">edit</a>]</h2>In early 2006, France’s President Jacques Chirac announced his decision to create a drug-purchase facility to advance international development projects, with France contributing 90 percent of its new airline ticket tax toward the endeavor.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-15" style="text-decoration-line: none; background: none;">[15]</a> Chile joined the effort, establishing its own airline ticket tax to support international development. That September, Unitaid was founded by Brazil, Chile, France, Norway and the United Kingdom.<h2 style="background: none rgb(255, 255, 255); font-weight: normal; margin: 1em 0px 0.25em; overflow: hidden; padding: 0px; border-bottom: 1px solid rgb(162, 169, 177); line-height: 1.3;">Structure[<a href="https://en.wikipedia.org/w/index.php?title=Unitaid&action=edit&section=4" title="Edit section: Structure" style="text-decoration-line: none; background: none;">edit</a>]</h2>The Executive Board, Unitaid’s decision-making body, determines the organization’s objectives, monitors progress and approves budgets. Representation on the 12-member Board includes Brazil, Chile, Norway, France, Spain and the United Kingdom, one member from Africa chosen by the African Union, one from Asia, two from civil society, one from the constituency of foundations, and one from the World Health Organization.<a href="https://en.wikipedia.org/wiki/Unitaid#cite_note-16" style="text-decoration-line: none; background: none;">[16]</a>Unitaid's founding Chair is <a href="https://en.wikipedia.org/wiki/Philippe_Douste-Blazy" title="Philippe Douste-Blazy" style="text-decoration-line: none; background: none;">Philippe Douste-Blazy</a>, former Foreign Minister of France.The Secretariat is currently led by an Executive Director (Lelio Marmora) and his Deputy (Philippe Duneton).<h2 style="background: none rgb(255, 255, 255); font-weight: normal; margin: 1em 0px 0.25em; overflow: hidden; padding: 0px; border-bottom: 1px solid rgb(162, 169, 177); line-height: 1.3;">See also[</h2><div class="div-col columns column-width" style="margin-top: 0.3em; background-color: rgb(255, 255, 255); column-width: 15em; width: 600px;"><ul style="list-style-image: url(" w="w" skins="skins" vector="Vector" resources="resources" skins.vector.styles="skins.vector.styles" images="images" bullet-icon.svg="bullet-icon.svg" d4515="d4515" margin="margin" px="px" em="em" padding="padding"><li style="margin-bottom: 0.1em; break-inside: avoid-column;"><a href="https://en.wikipedia.org/wiki/The_Global_Fund" class="mw-redirect" title="The Global Fund" style="text-decoration-line: none; background: none;">The Global Fund</a></li><li style="margin-bottom: 0.1em; break-inside: avoid-column;"><a href="https://en.wikipedia.org/wiki/WHO" class="mw-redirect" title="WHO" style="text-decoration-line: none; background: none;">WHO</a></li><li style="margin-bottom: 0.1em; break-inside: avoid-column;"><a href="https://en.wikipedia.org/wiki/UNICEF" title="UNICEF" style="text-decoration-line: none; background: none;">UNICEF</a></li><li style="margin-bottom: 0.1em; break-inside: avoid-column;"><a href="https://en.wikipedia.org/wiki/Clinton_Foundation" title="Clinton Foundation" style="text-decoration-line: none; background: none;">Clinton Foundation</a></li><li style="margin-bottom: 0.1em; break-inside: avoid-column;"><a href="https://en.wikipedia.org/wiki/Stop_TB_Partnership" title="Stop TB Partnership" style="text-decoration-line: none; background: none;">Stop TB Partnership</a></li><li style="margin-bottom: 0.1em; break-inside: avoid-column;"><a href="https://en.wikipedia.org/wiki/M%C3%A9decins_Sans_Fronti%C3%A8res" title="Médecins Sans Frontières" style="text-decoration-line: none; background: none;">Médecins Sans Frontières</a></li><li style="margin-bottom: 0.1em; break-inside: avoid-column;"><a href="https://en.wikipedia.org/wiki/UNAIDS" class="mw-redirect" title="UNAIDS" style="text-decoration-line: none; background: none;">UNAIDS</a></li><li style="margin-bottom: 0.1em; break-inside: avoid-column;"><a href="https://en.wikipedia.org/wiki/Millennium_Foundation" title="Millennium Foundation" style="text-decoration-line: none; background: none;">The Millennium Foundation</a></li><li style="margin-bottom: 0.1em; break-inside: avoid-column;"><a href="https://en.wikipedia.org/wiki/MassiveGood" class="mw-redirect" title="MassiveGood" style="text-decoration-line: none; background: none;">MassiveGood</a></li><li style="margin-bottom: 0.1em; break-inside: avoid-column;"><a href="https://en.wikipedia.org/wiki/Foundation_for_Innovative_New_Diagnostics" title="Foundation for Innovative New Diagnostics" style="text-decoration-line: none; background: none;">Foundation for Innovative New Diagnostics</a></li><li style="margin-bottom: 0.1em; break-inside: avoid-column;"><a href="https://en.wikipedia.org/wiki/Medicines_Patent_Pool" title="Medicines Patent Pool" style="text-decoration-line: none; background: none;">Medicines Patent Pool</a></li></ul></div><h2 style="background: none rgb(255, 255, 255); font-weight: normal; margin: 1em 0px 0.25em; overflow: hidden; padding: 0px; border-bottom: 1px solid rgb(162, 169, 177); line-height: 1.3;">References...</h2></div><div></div><div><a href="https://unitaid.org/">https://unitaid.org/</a></div><div>
</div><div><a href="https://unitaid.org/covid-19/#en">https://unitaid.org/covid-19/#en</a></div><div>
</div><div>Unitaid has moved quickly to reshape its programs to contribute to the global response to the COVID-19 pandemic.Working with its partners, Unitaid has identified opportunities to collaborate for impact on fast molecular tests, clinical trials of medicines and vital devices to check patients’ oxygen levels.New opportunities are continually being explored to ensure that the needs of the most vulnerable populations are being addressed in a way that is fair and timely.This page gives details of the different interventions that Unitaid is making to support the global efforts.<h3 style="box-sizing: border-box; border-width: 0px 0px 1px; border-top-style: initial; border-right-style: initial; border-bottom-style: solid; border-left-style: initial; border-top-color: initial; border-right-color: initial; border-bottom-color: rgb(216, 216, 216); border-left-color: initial; border-image: initial; outline: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: normal; font-stretch: normal; line-height: 1.2; vertical-align: baseline; margin: 40px 0px 20px; padding: 0px 0px 13px; text-size-adjust: 100%; background-color: rgb(255, 255, 255);">‘Coronavirus Global Response’ campaign (<a href="https://twitter.com/hashtag/GlobalResponse?src=hashtag_click" target="blank" rel="noopener" style="box-sizing: border-box; border: 0px; outline: 0px; vertical-align: baseline; margin: 0px; padding: 0px; text-decoration-line: none;">#GlobalResponse</a>) </h3>EU and global partners launch ‘Coronavirus Global Response’ <a href="https://europa.eu/global-response/" target="blank" rel="noopener" style="box-sizing: border-box; border: 0px; outline: 0px; vertical-align: baseline; margin: 0px; padding: 0px; text-decoration-line: none;">campaign</a>Pledging <a href="https://global-response.europa.eu/pledge_en" target="blank" rel="noopener" style="box-sizing: border-box; border: 0px; outline: 0px; vertical-align: baseline; margin: 0px; padding: 0px; text-decoration-line: none;">tracker</a></div><div>
</div><div>
</div><div>===</div></div>